Related Experiment Videos

Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation

Mimi Tamamori-Adachi1, Hiroshi Ito, Piyamas Sumrejkanchanakij

  • 1Department of Biochemical Genetics, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.

Circulation Research
|January 11, 2003
PubMed

Insights

Cardiomyocyte proliferation is blocked by cytoplasmic cyclin D1/CDK4. Nuclear import of cyclin D1/CDK4 via D1NLS/CDK4 triggers cell cycle reentry and division, offering potential for heart regeneration therapies.

Area of Science:

  • Cardiovascular Biology
  • Cell Cycle Regulation
  • Regenerative Medicine

Background:

  • Mammalian cardiomyocytes lose proliferative capacity post-birth, with mechanisms remaining unclear.
  • Cyclin D1 and CDK4 are crucial for cell cycle progression by phosphorylating Rb.
  • Postmitotic cardiomyocytes exhibit hypertrophic growth and cyclin D1 upregulation upon mitogenic stimulation.

Purpose of the Study:

  • To investigate the mechanisms preventing cardiomyocyte proliferation.
  • To determine if nuclear localization of cyclin D1/CDK4 can restore cardiomyocyte cell cycle reentry.
  • To explore therapeutic strategies for cardiomyocyte regeneration.

Main Methods:

  • Utilized neonatal rat cardiomyocytes and recombinant adenoviruses.
  • Constructed a nuclear localization signal (NLS) variant of cyclin D1 (D1NLS).
  • Assessed Rb phosphorylation, CDK2 kinase activity, cell division, Ki-67 expression, and BrdU incorporation.

Main Results:

  • Neonatal cardiomyocytes showed cytoplasmic cyclin D1/CDK4 and underphosphorylated Rb.
  • Ectopic cyclin D1 localized to the nucleus in fetal but not neonatal cardiomyocytes.
  • D1NLS/CDK4 coinfection induced Rb phosphorylation, CDK2 activity, and cell cycle reentry, increasing cardiomyocyte numbers threefold.
  • D1NLS/CDK4 promoted cell cycle reentry in adult cardiomyocytes in vivo.

Conclusions:

  • Nuclear import of cyclin D1/CDK4 is essential for cardiomyocyte proliferation.
  • Cytoplasmic sequestration of cyclin D1/CDK4 acts as a barrier to cardiomyocyte cell cycle reentry.
  • Targeting nuclear import of cyclin D1/CDK4 offers a promising therapeutic approach for cardiac regeneration.

Related Concept Videos